The company has not filed an annual or quarterly report since its Q2 FY2020 10-Q, filed Aug 10, 2020. Its latest SEC filing is a 15-12B from Nov 9, 2020.
10-Q for Q2 FY2020, filed Aug 10, 2020
The sections below describe the company as of the FY2019 annual report.
Provides connected devices, health supplies, personalized coaching and digital tools for people with chronic conditions, with employers, health plans and government entities as clients.
10-K for FY2019, filed Mar 24, 2020Our mission is to empower people with chronic conditions to live better and healthier lives. Livongo is pioneering a new category in…View ↗
We offer an integrated suite of solutions to promote sustainable health behavior change based on easy, real-time data capture supported by…View ↗
We sell to companies of all sizes, including employers, from small businesses to Fortune 500 enterprises, hospital payors government…View ↗
Clients, including employers, health plans and government entities, pay mainly monthly subscriptions for access to the integrated devices, supplies, platform and coaching, often priced by enrolled member; some agreements also include an upfront device fee.
10-K for FY2019, filed Mar 24, 2020Our solutions include a smart, cellular-connected device and related testing materials, if applicable, that are sent directly to the…View ↗
The substantial majority of our revenue is derived from monthly subscription fees that are recognized as services are rendered and earned…View ↗
In most agreements associated with our Livongo for Diabetes, Livongo for Hypertension, and Livongo for Prediabetes and Weight Management…View ↗
$170.2M
10-K for FY2019, filed Mar 24, 2020
$170.2M ↗
Employers, health plans, government entities and labor unions are clients. Livongo sells directly through its sales force and also through channel partners, pharmacy benefit managers and resellers.
10-K for FY2019, filed Mar 24, 2020
No. It lost $55.3M in .
10-K for FY2019, filed Mar 24, 2020
10-Q for Q2 FY2020, filed Aug 10, 2020
−$1.6MView ↗
8-K, filed Oct 30, 2020
Item 2.01. Completion of Acquisition or Disposition of Assets.View ↗
Grew.
Revenue grew 5.5x in 2 years, from $30.9M in to $170.2M in , about 135% a year.
10-K for FY2019, filed Mar 24, 2020
Competes with Virta Health, Omada Health, Glooko, Hello Heart, Lyra Health, Onduo, and Ginger.io
10-K for FY2019, filed Mar 24, 2020The market for our solutions is competitive and characterized by rapid change. The competitive success of our solutions is contingent on…View ↗
Loading...
